In last trading session, Sensei Biotherapeutics Inc (NASDAQ:SNSE) saw 0.61 million shares changing hands with its beta currently measuring 0.16. Company’s recent per share price level of $0.51 trading at -$0.02 or -3.30% at ring of the bell on the day assigns it a market valuation of $12.89M. That closing price of SNSE’s stock is at a discount of -280.39% from its 52-week high price of $1.94 and is indicating a premium of 25.49% from its 52-week low price of $0.38. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.15 million shares which gives us an average trading volume of 635.01K if we extend that period to 3-months.
For Sensei Biotherapeutics Inc (SNSE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Sensei Biotherapeutics Inc (NASDAQ:SNSE) trade information
Upright in the red during last session for losing -3.30%, in the last five days SNSE remained trading in the red while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $0.51 price level, adding 8.93% to its value on the day. Sensei Biotherapeutics Inc’s shares saw a change of 4.57% in year-to-date performance and have moved -0.49% in past 5-day. Sensei Biotherapeutics Inc (NASDAQ:SNSE) showed a performance of 11.17% in past 30-days. Number of shares sold short was 0.19 million shares which calculate 0.29 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 90.73% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -880.39% in reaching the projected high whereas dropping to the targeted low would mean a loss of -880.39% for stock’s current value.
Sensei Biotherapeutics Inc (SNSE) estimates and forecasts
Statistics highlight that Sensei Biotherapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -26.79% of value to its shares in past 6 months, showing an annual growth rate of 4.10% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -16.26% during past 5 years.
Sensei Biotherapeutics Inc (NASDAQ:SNSE)’s Major holders
Insiders are in possession of 34.39% of company’s total shares while institution are holding 8.81 percent of that, with stock having share float percentage of 13.43%. Investors also watch the number of corporate investors in a company very closely, which is 8.81% institutions for Sensei Biotherapeutics Inc that are currently holding shares of the company. IKARIAN CAPITAL, LLC is the top institutional holder at SNSE for having 0.65 million shares of worth $0.4 million. And as of 2024-06-30, it was holding 2.5949 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.4702 of outstanding shares, having a total worth of $0.38 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 485.96 shares of worth $0.25 million or 1.93% of the total outstanding shares. The later fund manager was in possession of 99.62 shares on Sep 30, 2024 , making its stake of worth around $51053.0 in the company or a holder of 0.40% of company’s stock.
